|
DPH5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.372200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.459600E-01 |
| Normal-vs-Stage2 |
3.973600E-01 |
| Normal-vs-Stage3 |
3.927700E-02 |
| Normal-vs-Stage4 |
3.598300E-02 |
| Stage1-vs-Stage2 |
1.006240E-01 |
| Stage1-vs-Stage3 |
6.165800E-02 |
| Stage1-vs-Stage4 |
9.816100E-02 |
| Stage2-vs-Stage3 |
1.648370E-02 |
| Stage2-vs-Stage4 |
1.707990E-02 |
| Stage3-vs-Stage4 |
8.165200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.698350E-01 |
| Normal-vs-AfricanAmerican |
2.072200E-01 |
| Normal-vs-Asian |
2.334800E-01 |
| Caucasian-vs-AfricanAmerican |
6.792600E-01 |
| Caucasian-vs-Asian |
8.454600E-01 |
| AfricanAmerican-vs-Asian |
7.992000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.789220E-01 |
| Normal-vs-Female |
3.377600E-01 |
| Male-vs-Female |
4.209600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.917400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.566400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.027200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.030430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.978600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.842000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.839200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.477800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.737200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.281000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.128230E-01 |
| Classical-VS-Follicular |
3.216600E-01 |
| Classical-VS-Other |
6.210000E-01 |
| Classical-VS-Normal |
3.079400E-01 |
| Tall-VS-Follicular |
3.484400E-02 |
| Tall-VS-Other |
3.557000E-01 |
| Tall-VS-Normal |
2.315600E-02 |
| Follicular-VS-Other |
7.615000E-01 |
| Follicular-VS-Normal |
9.848400E-01 |
| Other-VS-Normal |
8.002200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.655200E-01 |
| Normal-vs-N1 |
6.236300E-03 |
| N0-vs-N1 |
1.300320E-02 |
|
|
